ADRs End Higher; Himax Technologies, Teva Pharmaceutical Industries Trade Actively

International stocks trading in New York closed higher on Friday.

The BNY Mellon index of American depositary receipts rose 0.8% to 149.74. The European index increased 0.9% to 139.49. The Asian index went up 0.5% to 176.30. The Latin American index increased 0.7% to 238.04, nd the emerging-markets index rose 0.6% to 316.

Himax Technologies Inc. (HIMX), Shire PLC (SHPG), and Teva Pharmaceutical Industries Ltd. (TEVA) were among those with ADRs that traded actively.

Taiwan-based Himax Technologies, a supplier and manufacturer of display drivers and other semiconductor products, denied allegations of fraud made in a tweet published Wednesday by Citron Research. Himax reaffirmed its commitment to transparent and reliable shareholder communication, and its adherence to the highest standards of corporate governance. ADRs of Himax dropped 4.9% to $10.50.

Irish pharmaceutical company Shire on Friday named John Miller, senior vice president of finance, as its interim chief financial officer effective Jan. 1. Mr. Miller will remain interim CFO until Thomas Dittrich starts his employment with Shire as CFO in early 2018. Shire said in November that CFO Jeff Poulton would leave the company at the end of December. ADRs of Shire (SHPG) rose 3.2% to $148.

Israeli pharmaceutical company Teva could eliminate as many as 10,000 jobs across the world, more than 15% its total staff, Bloomberg reports. Kare Schultz, chief executive of the debt-ridden company, aims to cut expenses by between $1.5 billion and $2 billion over the next two years, according to Bloomberg. ADRs of Teva rose 7.1% to $16.06.

(END) Dow Jones Newswires

December 08, 2017 18:05 ET (23:05 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.